BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29419277)

  • 21. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bortin MM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2655-7. PubMed ID: 3274576
    [No Abstract]   [Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation.
    Tong J; Viale M; Bacigalupo A; PodestĂ  M; Sogno G; Tedone E; Marmont AM
    Haematologica; 1992; 77(4):365-6. PubMed ID: 1427449
    [No Abstract]   [Full Text] [Related]  

  • 26. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute graft-versus-host disease in allogeneic bone marrow transplantation].
    Harada M; Funada H; Yoshida T; Kodo H; Mori T; Matsue K; Shiobara S; Ohtake S; Odaka K; Teshima H
    Rinsho Ketsueki; 1984 Jul; 25(7):1043-51. PubMed ID: 6389930
    [No Abstract]   [Full Text] [Related]  

  • 28. Graft rejection and graft-versus-host disease in marrow transplantation.
    Storb R
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2915-8. PubMed ID: 2650395
    [No Abstract]   [Full Text] [Related]  

  • 29. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.
    Vogelsang GB; Hess AD; Berkman AW; Tutschka PJ; Farmer ER; Converse PJ; Santos GW
    N Engl J Med; 1985 Sep; 313(11):645-50. PubMed ID: 3894963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Johnsen HE
    N Engl J Med; 1993 May; 328(20):1497-8. PubMed ID: 8479479
    [No Abstract]   [Full Text] [Related]  

  • 32. Graft-versus-host disease after marrow transplantation.
    Lancet; 1984 Mar; 1(8375):491-2. PubMed ID: 6142212
    [No Abstract]   [Full Text] [Related]  

  • 33. T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
    Champlin R
    J Hematother; 1993; 2(1):27-42. PubMed ID: 7921964
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
    Mori A; Hashino S; Imamura M; Kahata K; Kawakami H; Shibata M; Kobayashi S; Tanaka J; Asaka M
    Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft-versus-host disease following bone marrow transplantation.
    Stutzer C; DeCuir-Whalley S
    J Assoc Pediatr Oncol Nurses; 1984; 1(4):11. PubMed ID: 6397585
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
    Noga SJ; Hess AD
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):28-33. PubMed ID: 8211214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Kai S; Shinohara Y; Ifuku H; Ohe Y; Misawa M; Noguchi K; Kohsaki M; Kanamaru A; Hara H; Nagai K
    Rinsho Ketsueki; 1985 Jan; 26(1):20-7. PubMed ID: 3889401
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute Graft-versus-Host Disease.
    Zeiser R; Blazar BR
    N Engl J Med; 2018 Feb; 378(6):586. PubMed ID: 29414273
    [No Abstract]   [Full Text] [Related]  

  • 39. Bronchiectasis: pulmonary manifestation in chronic graft versus host disease after bone marrow transplantation.
    Tanawuttiwat T; Harindhanavudhi T
    Am J Med Sci; 2009 Apr; 337(4):292. PubMed ID: 19365179
    [No Abstract]   [Full Text] [Related]  

  • 40. Graft-versus-host disease.
    Vogelsang GB; Wagner JE
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):625-39. PubMed ID: 2193015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.